N-AcetylCysteine, Hypertonic Saline and Mannitol in Chronic Respiratory Diseases; Efficiency and Safety Considerations
M Shohrati, A Taheri, H Borna… - Journal of Advances in …, 2016 - archive.sdpublishers.com
… According to the guidelines of therapy, inhaled corticosteroids, inhaled beta2-agonists,
methylxanthines and phosphodiesterase inhibitors are main current agents for the treatment of …
methylxanthines and phosphodiesterase inhibitors are main current agents for the treatment of …
[HTML][HTML] Treatment with oral or inhaled bronchodilator without inhaled corticosteroids in bronchial asthma: A dangerous weapon!
S Patil, S Toshniwal, G Gondhali - Annals of Medical Science & …, 2023 - journals.lww.com
… patients who have separate beta2-agonists and corticosteroid inhalers may choose to take
less corticosteroid because of better symptom control from the inhaled beta2-agonists, and it …
less corticosteroid because of better symptom control from the inhaled beta2-agonists, and it …
[HTML][HTML] Tiotropium bromide/olodaterol (Stiolto Respimat): once-daily combination therapy for the maintenance of COPD
JF Mosley, LL Smith, BN Dutton - Pharmacy and Therapeutics, 2016 - ncbi.nlm.nih.gov
… Several drug classes are used to treat COPD, including anticholinergic agents, short-and
long-acting beta2 agonists (LABAs), inhaled corticosteroids, and phosphodiesterase 4 (PDE4) …
long-acting beta2 agonists (LABAs), inhaled corticosteroids, and phosphodiesterase 4 (PDE4) …
Comparative study of an asthmatic patient on using different drugs and therapies
M Singh, AR Pathania - AIP Conference Proceedings, 2023 - pubs.aip.org
… Long-acting beta2-agonists are also more effective than standard short-acting beta2-agonists
and theophylline in controlling asthma[[9]-[10]. They vary slightly in mode and duration of …
and theophylline in controlling asthma[[9]-[10]. They vary slightly in mode and duration of …
[引用][C] Molecular Systems Design & Engineering
P Muralidharan, D Hayes Jr, SM Blackd, HM Mansour
Impact of family socioeconomic position on childhood asthma outcomes, severity, and specialist referral–a Danish nationwide study
M Renzi-Lomholt, CS Ulrik, D Rastogi… - Chronic Respiratory …, 2024 - journals.sagepub.com
… Outcomes were uncontrolled (excessive use of short-acting beta2-agonists), exacerbating
(oral corticosteroid use or hospitalization), and severe asthma (according to GINA 2020). …
(oral corticosteroid use or hospitalization), and severe asthma (according to GINA 2020). …
[PDF][PDF] Pulmonary function and medication use are associated with physical activity in very mild to moderate COPD: a population based study
AR van Buul, MJ Kasteleyn… - Chronic …, 2019 - scholarlypublications …
… The presence of long-acting muscarinic antagonists (LAMA) and a combination of inhaled
corticosteroids (ICS)/long-acting beta2 agonists (LABA)/LAMA were associated with less …
corticosteroids (ICS)/long-acting beta2 agonists (LABA)/LAMA were associated with less …
Analysis of modern and korean medicine treatments for chronic obstructive pulmonary disease
HC Jung, KH Min, YR Won - 셀메드, 2024 - dbpia.co.kr
… Beta2-agonists: They act on the smooth muscles surrounding the … They can also be used in
combination with beta2agonists. … They are usually used in combination with beta2agonists or …
combination with beta2agonists. … They are usually used in combination with beta2agonists or …
Tremor and Paradoxical bronchospasm caused by Terbutaline
D Wang, J Liu, B Liang, J Zhang, Y Zhou, X Zhang - 2023 - researchsquare.com
… admitted to hospital with acute bronchitis.The main complaints … cases following inhalation of
short-acting beta2 agonists [1, 4].No … In this paper, we report a case of severe bronchospasm …
short-acting beta2 agonists [1, 4].No … In this paper, we report a case of severe bronchospasm …